A

Atossa Therapeutics
D

ATOS

0.79610
USD
-0.04
(-5.21%)
Market Closed
Volume
2,132
EPS
-0
Div Yield
-
P/E
-4
Market Cap
100,150,378
OverviewSignalsIdeasNews
Related Instruments
    A
    ARCT
    0.846
    (5.00%)
    17.770 USD
    B
    BNGO
    0.01500
    (0.28%)
    5.36500 USD
    C
    CODX
    0.01720
    (2.46%)
    0.71700 USD
    I
    IDT
    -0.890
    (-1.80%)
    48.610 USD
    I
    INO
    0.02000
    (0.91%)
    2.23000 USD
    T
    TNXP
    -0.53000
    (-5.48%)
    9.15000 USD
    V
    VXRT
    0.00670
    (0.95%)
    0.70980 USD
    More
News

Title: Atossa Therapeutics

Sector: Healthcare
Industry: Biotechnology
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.